Unclaimed Scholar Profile
Are you Vicky Lynne Baillie? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-2250-8486-8289 orcid.org/0000-0003-1327-9090
Vicky Lynne Baillie
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Pneumonia and Respiratory Infections#SARS-CoV-2 and COVID-19 Research#Respiratory viral infections research#COVID-19 Clinical Research Studies
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 16,010 | 7,685 |
| h-index | 39 | 29 |
| i10-index | 64 | 45 |
Annual Citation Growth
Verified Citations / Year0
2020769
2021+40%1.1k
2022+29%1.4k
2023+33%1.8k
2024-8%1.7k
2025-45%922
2026Scholarship Distribution & Proportions103 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (13,128) • 18% Global Research Impact (2,882)
103 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (103)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
DOI: 10.1016/s0140-6736(17)30938-8 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Published in Cell•2022
DOI: 10.1016/j.cell.2021.12.046 Verified Peer-Reviewed
Showing 1 – 5 of 103 publications
1 / 21